| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Revenue | $15.1B | $14.9B | $15.6B | $16.7B | $13.8B | $4.7B | $4.6B | $4.8B |
| Cost of Revenue | $8.9B | $9.1B | $10.3B | $10.0B | $9.1B | $10.3B | — | — |
| Gross Profit | $6.2B | $5.8B | $5.4B | $6.6B | $4.7B | $1.7B | $1.6B | $1.8B |
| R&D Expense | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.0B | $0.1B | — |
| SG&A Expense | — | — | — | — | — | — | — | — |
| Operating Income | $1.1B | $0.6B | $-0.1B | $0.8B | $-0.9B | $0.6B | $1.4B | $1.5B |
| Net Income | $0.8B | $0.5B | $-0.2B | $0.3B | $-0.7B | $-0.2B | $0.3B | $0.2B |
| EPS (Basic) | $2.24 | $1.36 | $-0.55 | $0.68 | $-1.78 | $-0.49 | $0.72 | $0.53 |
| EPS (Diluted) | $2.20 | $1.34 | $-0.55 | $0.67 | $-1.78 | $-0.49 | $0.72 | $0.52 |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Total Assets | $11.9B | $11.0B | $11.4B | $12.8B | $13.8B | $13.7B | $8.0B | $8.0B |
| Current Assets | $5.2B | $4.4B | $4.6B | $5.2B | $6.0B | $4.5B | $4.3B | $4.6B |
| Cash & Equivalents | $2.3B | $1.9B | $1.2B | $0.9B | $2.0B | $1.4B | $1.1B | $1.8B |
| Total Liabilities | — | — | — | — | — | — | — | — |
| Current Liabilities | $3.3B | $3.1B | $3.3B | $4.1B | $3.9B | $3.2B | $2.2B | $2.5B |
| Stockholders' Equity | $3.3B | $2.6B | $2.2B | $2.7B | $2.6B | $3.3B | $3.6B | $3.1B |
| Metric | FY 2024↕ | FY 2023↕ | FY 2022↕ | FY 2021↕ | FY 2020↕ | FY 2019↕ | FY 2018↕ | FY 2017↕ |
|---|---|---|---|---|---|---|---|---|
| Operating Cash Flow | $1.5B | $1.5B | $0.6B | $0.8B | $0.2B | $1.4B | $1.4B | $1.4B |
| Investing Cash Flow | $-0.7B | $-0.3B | $-0.2B | $-0.4B | $-0.5B | $-0.9B | $-1.0B | $-0.7B |
| Capital Expenditures | $0.4B | $0.4B | $0.7B | $0.7B | $0.4B | $0.7B | $0.7B | $0.7B |
| Financing Cash Flow | $-0.3B | $-0.6B | $0.0B | $-1.5B | $0.9B | $-0.6B | $-0.7B | $-0.7B |